Compared to usual care, participants who used GLP-1RAs had a lower risk of: substance use and psychotic disorders seizures neurocognitive disorders including Alzheimers disease and dementia infectious illnesses several respiratory conditions coagulation and cardiometabolic disorders, including deep vein thrombosis, pulmonary embolism, stroke, cardiac arrest, heart failure and myocardial infarction
NAD+ supports cellular energy production and overall metabolic function, aiding in anti-ageing and brain health
Diarrhea is more common with tirzepatide, while semaglutide users may experience constipation instead
Yaku, K., Okabe, K., Hikosaka, K., & Nakagawa, T
Another recent study discovered that 99% of bottled water brands contain PFAS, presenting limited options for consumers seeking safer alternatives
Compounded semaglutide injection from licensed 503A pharmacies contains the same active ingredient as Ozempic